Summary Transurethral resection of the prostate (TURP) as an excisional procedure involving multiple incisions into the prostate does not differentiate between palpably benign prostate tissue and microscopic foci of well-differentiated adenocarcinoma. The impact of TURP on the progression of such 'latent' or 'incidental' tumours unique to the prostate gland has been a focal point of a continuing controversy. In studies designed to develop preclinical evidence that would lend support to, or detract from, either side of the TURP controversy, surgical trauma-induced stimulation of in situ tumour growth was extended to include human prostate tumour tissue PC-3, DU-145 and H-1579, albeit (Coplen et al., 1991 ). An astonishingly high prevalence of what pathologists have interpreted as microscopic foci of well-differentiated adenocarcinoma has been found at autopsy in serial sections of prostate glands considered to be normal from men over the age of 50. Every decade of ageing nearly doubles the incidence of such tumours -from 10% in men in their 50s to 70% in men in their 80s (Scott et al., 1969; Sheldon et al., 1980) . Such a prevalence of 'latent' or 'incidental' tumours appears to be unique to the prostate gland (Silverberg and Lubera, 1989) . The biological potential of focal low-grade, incidentally discovered prostatic cancer (stage Al) has generally been believed to be relatively innocuous, although this view has been challenged in recent years by several groups who have found a 16-27% rate of disease progression in patients followed for extended periods (Blute et al., 1986; Epstein et al., 1986) . The phenomenon of tumour cell dissemination by surgical manipulation has been investigated with various surgical procedures and tumour types and is hardly a fresh topic. It has, however, become an important concept for exploration with regard to prostatic carcinoma, considering both the incidence of this particular tumour and the frequency with which TURP has been performed for obstructive symptoms. The actual impact of TURP on the development of metastases, however, is not well defined. McGowan (1980) has reported that the 5 year actuarial disease-free survival of patients with clinical stage B and C tumours treated by radiation therapy is significantly lower for patients who have undergone prior TURP compared with patients who have not undergone prior TURP. Further, it has been speculated that the relatively poor prognosis of patients with stage A2 prostatic tumours may be related to tumour dissemination during TURP (Walsh, 1980 al., 1983) or to the possibility that the patients who were selected for TURP had a higher incidence of clinically occult metastases before the procedure bears upon the influences of the method of diagnosis (TURP vs needle biopsy) on patient outcome, which is also controversial (Hanks et al., 1986; Kuban et al., 1987; McGowan, 1988) .
Although most patients with a palpably benign prostate who undergo transurethral resections of the prostate (TURP) for obstructive voiding symptoms have benign prostatic hyperplasia (BHP), prostate cancer has been an incidental finding in 19% of patients during prostatectomy for BPH (Agatstein et al., 1987) and in 10% of men with a clinical diagnosis of BPH who underwent multiple directed and systematic ultrasound-guided biopsies of the prostate (Coplen et al., 1991 ). An astonishingly high prevalence of what pathologists have interpreted as microscopic foci of well-differentiated adenocarcinoma has been found at autopsy in serial sections of prostate glands considered to be normal from men over the age of 50. Every decade of ageing nearly doubles the incidence of such tumours -from 10% in men in their 50s to 70% in men in their 80s (Scott et al., 1969; Sheldon et al., 1980) . Such a prevalence of 'latent' or 'incidental' tumours appears to be unique to the prostate gland (Silverberg and Lubera, 1989) . The biological potential of focal low-grade, incidentally discovered prostatic cancer (stage Al) has generally been believed to be relatively innocuous, although this view has been challenged in recent years by several groups who have found a 16-27% rate of disease progression in patients followed for extended periods (Blute et al., 1986; Epstein et al., 1986) . The phenomenon of tumour cell dissemination by surgical manipulation has been investigated with various surgical procedures and tumour types and is hardly a fresh topic. It has, however, become an important concept for exploration with regard to prostatic carcinoma, considering both the incidence of this particular tumour and the frequency with which TURP has been performed for obstructive symptoms. The actual impact of TURP on the development of metastases, however, is not well defined. McGowan (1980) has reported that the 5 year actuarial disease-free survival of patients with clinical stage B and C tumours treated by radiation therapy is significantly lower for patients who have undergone prior TURP compared with patients who have not undergone prior TURP. Further, it has been speculated that the relatively poor prognosis of patients with stage A2 prostatic tumours may be related to tumour dissemination during TURP (Walsh, 1980) . Whether
Correspondence: AE Bogden Received 21 June 1995; accepted 18 August 1995 the higher incidence of metastases seen in patients who had TURP is due to the iatrogenic dissemination of malignant cells (Hanks et al., 1983) or to the possibility that the patients who were selected for TURP had a higher incidence of clinically occult metastases before the procedure bears upon the influences of the method of diagnosis (TURP vs needle biopsy) on patient outcome, which is also controversial (Hanks et al., 1986; Kuban et al., 1987; McGowan, 1988) .
In a retrospective analysis of 225 patients with localised adenocarcinoma of the prostate who were treated with continuous-course external-beam radiation therapy, Amdur et al. (1990) found that the 5 year rate of distant metastasis was significantly greater in patients with stage C disease when the biopsy was made by TURP, rather than by needle biopsy, lending support to series that claim that diagnosis by TURP reduces the likelihood of long-term relapse-free survival. The method of diagnosis was not prognostically important, however, in patients with stage B disease. A multivariate Cox's hazard function analysis was performed by Forman et al. (1986) on the prognostic variables selected from 240 patients with localised carcinoma of the prostate, who received external-beam radiotherapy, to analyse the association between the method of biopsy and disease-free survival. Median follow-up was 4 years. A multivariable analysis demonstrated that 'method of biopsy', was the third most powerful variable after serum acid phosphatase level and modified Broder's grade in predicting disease-free survival. Patients who had TURP had an almost 2-fold higher relative risk of disease progression than those who had needle biopsy.
The recent report by Zagars et al. (1993) (Hanks et al., 1983; Forman et al., 1986; McGowan 1987; Perez et al., 1989; Amdur et al., 1990) but there are reports that such an association does not exist (Anscher and Prosnitz, 1991) Group Figure 3 Inhibiting the trauma-induced accelerated growth of human prostate tumour xenografts by treating the surgical lesion topically with Lanreotide. PC-3 tumour xenografts were implanted s.c. in non-traumatised animals, (group 1; ) and intralesionally in traumatised animals (group 5; 1111), as untreated controls. Group 3 ( 1 ) and group 4 ( 1 ) animals were implanted s.c. in the flank opposite (distant) from the surgical lesion in traumatised animals and had their respective trauma sites treated topically with the 10% DMSO/saline vehicle (group 3) or Lanreotide (group 4). non-traumatised animals (group 1). By day 30 post implantation tumour sizes were significantly greater in the surgically traumatised animals whether the tumour had been implanted into the site of trauma (P = 0.004) or in the site away from the trauma (P = 0.0 14). Importantly, proximity of malignant tissue to the trauma increased the proliferative response over that of malignant tissue implanted distant to the trauma by a factor of 3 (P<0.05). Figure 2b compares the proliferative response of PC-3 and Figure 2c compares the proliferative response of DU-145 implanted into the traumatised area (group 2) and distally from the trauma (group 3) as well as in non-traumatised (group 1) animals. By day 26 post implantation both tumours exhibited significantly greater growth in traumatised compared with non-traumatised animals whether implanted into the site of trauma (DU-145, P = 0.001; PC-3, P = 0.002) or the site away from the trauma (DU-145, P = 0.06; PC-3, P = 0.03). In all instances proximity of the malignant tissue to the surgically treated site resulted in a significantly increased rate of tumour growth.
Inhibiting the surgical trauma-induced proliferative surge of human prostate tumour xenografts In previous studies (Bogden et al., 1993 ) with a number of transplantable human and animal tumours we have been able to confirm a long-recognised phenomenon, the surgical trauma-induced proliferative surge of in situ malignant tissues. Of particular significance in these early studies was our ability to inhibit the proliferative surge by topical application of LAN to the surgical site.
Expanding these observations to include human prostate tumours (Figure 3) growth when compared with the trauma only control (P <0.001) and further inhibited tumour growth significantly (P = 0.01) better than treatment with the vehicle alone (group 3). Treatment of the trauma site over the 15 day period with LAN had completely inhibited the traumainduced proliferative surge maintaining tumour growth at the level of the non-traumatised shelf control (group 1). Table I summarises the results obtained with different treatment protocols designed to demonstrate the inhibitory effect on prostate tumour growth by treating the trauma site with LAN. In assay BL94-610 and BL93-605, animals were implanted with the appropriate prostate tumour s.c., right flank, in the morning of day 0. In the evening of the same day surgical trauma was induced in the left flank. Within 2-3 h post traumatisation, LAN at a concentration of 500 tg 0.05 ml1' 10% DMSO/saline was applied topically to the wound area with gentle rubbing for 1 min. There were no additional treatments. On day 27 post implantation, the H-1579 human prostate tumour still exhibited significant (P<0.01) inhibition with a 66% test-control ratio (T/C). By day 15 post implantation, the PC-3 human prostate tumour was also inhibited with a 57% T/C, which was not statistically significant.
In assay BL93-510 animals were surgically traumatised on the left flank in the morning of day 0, the PC-3 tumour implanted in the right flank in the evening of day 0, and treatment of the traumatised area was initiated on day 1. LAN was administered topically at a concentration of 500 ,ug 0.05 ml-' in a 40% DMSO/saline vehicle, b.i.d., on days 1-25. PC-3 exhibited a slight inhibitory effect (74% T/C) that was not statistically significant in animals with wound areas treated only with the 40% DMSO/saline vehicle. However, in animals treated similarly with LAN in the same vehicle inhibition of PC-3 was statistically significant (P = 0.017), inducing a 65% T/C.
In assay BL93-593 the left flanks of animals were surgically traumatised in the morning of day 0. Within 2 h of traumatisation animals were implanted s.c. in the opposite or right flank with xenografts of the DU-145 prostate tumour. Treatment of the trauma site with topically applied LAN in a 10% DMSO/saline vehicle was initiated in the morning of day 0 and continued on a twice-daily regimen for days 0-26. Treatment of the trauma site with the 10% DMSO/saline vehicle alone had a slight inhibitory effect (59% T/C) that was not statistically significant. Treatment of the trauma site with LAN, however, induced a 20% T/C that was significant at the P<0.05 level).
Effect of LAN on wound breaking strength An early inhibitory effect (day 5 after surgical wounding) was observed, which was reversed on day 10 suggesting, that when applied topically to a wound area, LAN slightly delays the initiation of collagen synthesis at the wound site (Table  II) . This effect coincides with the time-defined window of 2-3 days duration post surgery in which trauma-induced factors stimulate a proliferative surge of distant in situ tumours. aSignificantly different from control (P<0.01) on day 5 only. Marie and Clunet (1910) and by Tyzzer (1913) . Of particular relevance to our studies was the relatively more recent observation by Simpson-Herren et al. (1976) . A surgical procedure that was designed to simulate tumour excision but left both the primary tumour and its spontaneous metastases undisturbed resulted in an increase in the thymidine index of Lewis lung pulmonary metastases, and a decrease in lifespan. In addition, however, the thymidine index of the primary tumours was also increased. (Schatten, 1958 , Romsdahl, 1964 , Riggins and Ketcham, 1965 Rudenstam, 1968; Simpson-Herren et al., 1974) . Prostatectomy for benign disease is a misnomer (Schwartz et al., 1986 (Denton et al., 1965; Coplen et al., 1991 (McNeal 1993) . This assumption is supported by the finding that in a population of 198 BPH patients subjected to TURP 10 nonpalpable prostate cancers were detected at surgery, one patient having a high-grade and nine having a low-grade cancer (Hammarsten et al., 1994) . However, in the same study three of ten patients having undergone TURP with stage Ti cancer developed clinical prostatic cancers in a 10 year follow-up period. This progression rate in stage Ti cancers is confirmed by findings in other studies that approximately 25% of patients with prostate cancer unexpectedly detected at operation for BPH had disease progression during an average of 10 years of follow-up (Lowe and Listrom 1988; Johansson et al., 1992) . Although the incidence of clinical prostate cancer resulting from progression of stage Ti lesions may appear low, the burden on the health care system is substantial since more than one million men undergo TURP every year (Hammarsten et al., 1994 
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